PLEASANTON, Calif.--(BUSINESS WIRE)--Calyxo, Inc., a medical device company redefining kidney stone treatment, today announced the closing of a $40 million Series F financing round, led by Ally Bridge ...

PLEASANTON, Calif.--(BUSINESS WIRE)--Calyxo, Inc., a medical device company developing innovative solutions for patients with kidney stones, announced that it has received FDA clearance for its new, ...

-- Dana G. Mead, Jr. brings 30 years of expertise in product strategy, development and commercialization to the Calyxo boardroom, as the company marks its next stage of growth. -- More than 20,000 ...

Calyxo announced today that it closed a Series F financing round worth $40 million to support its kidney stone removal tech.

Calyxo, Inc., a medical device company revolutionizing kidney stone treatment, today announced the presentation of six new abstracts at the 41 st Annual European Association of Urology Annual Congress ...

The FDA has issued an early alert regarding a potential safety issue with Calyxo’s CVAC Aspiration System, warning that improper use can lead to serious injury or death. On Feb. 19, Calyxo notified ...

Calyxo, Inc., a medical device company advancing innovative solutions for kidney stone treatment, announced today that Joe Catanese, Ph.D., Chief Executive Officer of Calyxo will present at the J.P.

-- More than 20,000 patients have been treated with the CVAC System, underscoring the increasing adoption of the SURE procedure and its impact in kidney stone care. “Calyxo is at an exciting ...

Calyxo has raised $40m in a financing round; at the same time, the company has achieved a milestone of 40,000 kidney stone removal procedures completed with its central venous access catheter (CVAC) ...